Using wastewater-based epidemiology to estimate drug consumption-Statistical analyses and data presentation.

AIM Analysis of wastewater samples can be used to assess population drug use, but reporting and statistical issues have limited the utility of the approach for epidemiology due to analytical results that are below the limit of quantification or detection. Unobserved or non-quantifiable-censored-data are common and likely to persist as the methodology is applied to more municipalities and a broader array of substances. We demonstrate the use of censored data techniques and account for measurement errors to explore distributions and annual estimates of the daily mean level of drugs excreted per capita. MEASUREMENTS Daily 24-hour composite wastewater samples for 56days in 2009 were obtained using a random sample stratified by day of week and season for 19 municipalities in the Northwest region of the U.S. METHODS Methamphetamine, benzoylecgonine (cocaine metabolite), 3,4 methylenedioxymethamphetamine (MDMA), methadone, oxycodone and hydrocodone were identified and quantified in wastewater samples. Four statistical approaches (reporting censoring, Maximum Likelihood Estimation, Kaplan-Meier estimates, or complete data calculations) were used to estimate an annual average, including confidence bounds where appropriate, dependent upon the amount of censoring in the data. FINDINGS The proportion of days within a year with censored data varied greatly by drug across the 19 municipalities, with MDMA varying the most (4% to 94% of observations censored). The different statistical approaches each needed to be used given the levels of censoring of measured drug concentrations. Figures incorporating confidence bounds allow visualization of the data that facilitates appropriate comparisons across municipalities. CONCLUSIONS Results from wastewater sampling that are below detection or quantification limits contain important information and can be incorporated to create a more complete and valid estimate of drug excretion.

[1]  D. Calamari,et al.  Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse , 2005, Environmental health : a global access science source.

[2]  M. Evans-Brown,et al.  New Psychoactive Substances in Europe. An Update from the EU Early Warning System , 2015 .

[3]  Christian G. Daughton,et al.  Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit-Abused Drugs and Their Potential for Ecological Consequences , 2001 .

[4]  C. Maynard,et al.  Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges , 2011, Journal of Urban Health.

[5]  Christoph Ort,et al.  Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. , 2010, Environmental science & technology.

[6]  C. Banta-Green,et al.  Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in population. , 2012, Environmental science & technology.

[7]  A. Scheidegger,et al.  Challenges of surveying wastewater drug loads of small populations and generalizable aspects on optimizing monitoring design. , 2014, Addiction.

[8]  Ettore Zuccato,et al.  Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. , 2006, Analytical chemistry.

[9]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[10]  Masoud Kayhanian,et al.  Statistical approaches to estimating mean water quality concentrations with detection limits. , 2002, Environmental science & technology.

[11]  Steve Carter,et al.  Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment. , 2011, Water research.

[12]  Y. Picó,et al.  Occurrence and removal of drugs of abuse in Wastewater Treatment Plants of Valencia (Spain). , 2014, Environmental pollution.

[13]  W. Ling,et al.  A Comparison of Patterns of Methamphetamine and Cocaine Use , 2001, Journal of addictive diseases.

[14]  M. Golden,et al.  Epidemiology of MDMA and Associated Club Drugs in the Seattle Area , 2005, Substance use & misuse.

[15]  C. Banta-Green,et al.  Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewaters. , 2008, Environmental science & technology.

[16]  R. Dart,et al.  Trends in opioid analgesic abuse and mortality in the United States. , 2015, The New England journal of medicine.

[17]  Steve Carter,et al.  Systematic and day-to-day effects of chemical-derived population estimates on wastewater-based drug epidemiology. , 2015, Environmental science & technology.

[18]  Christoph Ort,et al.  Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. , 2010, Environmental science & technology.

[19]  Ronny Blust,et al.  Cocaine and metabolites in waste and surface water across Belgium. , 2009, Environmental pollution.

[20]  C. Metcalfe,et al.  Illicit drugs in Canadian municipal wastewater and estimates of community drug use. , 2010, Environmental pollution.

[21]  Lubertus Bijlsma,et al.  LC-QTOF MS screening of more than 1,000 licit and illicit drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia , 2015, Analytical and Bioanalytical Chemistry.

[22]  Dennis R. Helsel,et al.  Statistics for Censored Environmental Data Using Minitab and R , 2012 .

[23]  C. Hignite,et al.  Drugs and Drug Metabolites as Environmental Contaminants: Detection of Chlorophenoxyisobutyrate and Salicylic Acid by GC-MS , 1977 .

[24]  P. Thai,et al.  Commentary on Ort et al. (2014): What next to deliver on the promise of large scale sewage-based drug epidemiology? , 2014, Addiction.

[25]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[26]  M. Warner,et al.  Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009. , 2013, American journal of preventive medicine.

[27]  Karin A Mack,et al.  Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.

[28]  Luc de Montigny,et al.  The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater. , 2009, Addiction.

[29]  Jery R. Stedinger,et al.  Estimation of Moments and Quantiles using Censored Data , 1996 .

[30]  W. Maho,et al.  Sewage-based epidemiology in monitoring the use of new psychoactive substances: Validation and application of an analytical method using LC-MS/MS. , 2015, Drug testing and analysis.

[31]  Christopher M. Jones,et al.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013 , 2015, MMWR. Morbidity and mortality weekly report.

[32]  Paul Griffiths,et al.  UvA-DARE ( Digital Academic Repository ) Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis , 2014 .

[33]  D. Helsel More than obvious: better methods for interpreting nondetect data. , 2005, Environmental science & technology.

[34]  Christoph Ort,et al.  Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. , 2013, Environmental science & technology.

[35]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .